Abstract:Machine learning methods offer time- and cost-effective means for identifying novel chemical matter as well as guiding experimental efforts to map enormous compound-kinase interaction spaces. However, considerable challenges for compound-kinase interaction modeling arise from the heterogeneity of available bioactivity readouts, including single-dose compound profiling results, such as percentage inhibition, and multi-dose-response results, such as IC . Standard activity prediction approaches utilize only dose-response data in the model training, disregarding a substantial portion of available information contained in single-dose measurements. Here, we propose a novel machine learning methodology for compound-kinase activity prediction that leverages both single-dose and dose-response data. Our two-stage model first learns a mapping between single-dose and dose-response bioactivity readouts, and then generates proxy dose-response activity labels for compounds that have only been tested in single-dose assays. The predictions from the first-stage model are then integrated with experimentally measured dose-response activities to model compound-kinase binding based on chemical structures and kinase features. We demonstrate that our two-stage approach yields accurate activity predictions and significantly improves model performance compared to training solely on dose-response labels, particularly in the most practical and challenging scenarios of predicting activities for new compounds and new compound scaffolds. This superior performance is consistent across five evaluated machine learning methods, including traditional models such as random forest and kernel learning, as well as deep learning-based approaches. Using the best performing model, we carried out extensive experimental profiling on a total of 347 selected compound-kinase pairs, achieving a high hit rate of 40% and a negative predictive value of 78%. We show that these rates can be improved further by incorporating model uncertainty estimates into the compound selection process. By integrating multiple activity data types, we demonstrate that our approach holds promise for facilitating the development of training activity datasets in a more efficient and cost-effective way.

A bioactivity foundation model using pairwise meta-learning

Case-Based Meta-Prediction for Bioinformatics.

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

Improved prediction of ligand-protein binding affinities by meta-modeling

BioAct-Het: A Heterogeneous Siamese Neural Network for Bioactivity Prediction Using Novel Bioactivity Representation

Embracing assay heterogeneity with neural processes for markedly improved bioactivity predictions

Leveraging multiple data types for improved compound-kinase bioactivity prediction

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery

Advancing Bioactivity Prediction through Molecular Docking and Self-Attention

Meta-MolNet: A Cross-Domain Benchmark for Few Examples Drug Discovery

Multi-task Bioassay Pre-training for Protein-ligand Binding Affinity Prediction

Biological Activity Predictions of Ligands Based on Hybrid Molecular Fingerprinting and Ensemble Learning

Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT

Prediction of chemical compounds properties using a deep learning model

Finding the most potent compounds using active learning on molecular pairs

An Analysis of Proteochemometric and Conformal Prediction Machine Learning Protein-Ligand Binding Affinity Models

FEP Augmentation as a Means to Solve Data Paucity Problems for Machine Learning in Chemical Biology

A Foundation Model for Chemical Design and Property Prediction

Learning Binding Affinities via Fine-tuning of Protein and Ligand Language Models